You just read:

IDEAYA Biosciences Announces AACR Abstracts for IDE196 Targeting GNAQ/11 Tumors and Preclinical MAT2A Synthetic Lethality Program

News provided by

IDEAYA Biosciences, Inc.

May 15, 2020, 06:00 ET